1 0

    FDA FAERS Reports – IZERVAY (Oct 24–30, 2024)

    FDA FAERS Reports – IZERVAY (Oct 24–30, 2024)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: I would like to request full reports of any and all adverse events reported to the FAERS database for IZERVAY (branded name / marketed by Astellas Pharma Inc.) or avacincaptad pegol intravitreal solution (generic name) between October 24, 2024, and October 30, 2024. Please provide the documents electronically if possible.
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details